Targeting sub-cellular organelles for boosting precision photodynamic therapy

Gopal Singh Attar1, Manoj Kumar1, Vandana Bhalla1

  • 1Department of chemistry UGC Sponsored-Centre for Advanced Studies-I, Guru Nanak Dev University, Amritsar-143005, Punjab, India. Gopal24chemistry@gmail.com.

Chemical Communications (Cambridge, England)
|September 25, 2024
PubMed

Insights

Targeted photodynamic therapy uses specific organelle-targeting photosensitizers for precise cancer treatment. This approach enhances efficiency, reduces toxicity, and minimizes recurrence by triggering organelle-mediated cell death.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Photochemistry

Background:

  • Photodynamic therapy (PDT) is a promising non-invasive cancer treatment.
  • Organelle-specific PDT offers enhanced precision and reduced side effects.
  • Targeting organelles triggers specific cell death pathways for improved outcomes.

Purpose of the Study:

  • To review recent advancements in organelle-targeted photodynamic therapy.
  • To highlight representative photosensitizers for specific organelle targeting.
  • To discuss organelle structure and mediated cell death signaling in PDT.

Main Methods:

  • Comprehensive literature review of organelle-targeted PDT.
  • Analysis of photosensitizers targeting endoplasmic reticulum, Golgi apparatus, mitochondria, nucleus, and lysosomes.
  • Focus on structure-activity relationships and cell death mechanisms.

Main Results:

  • Organelle-specific PDT significantly enhances therapeutic efficacy.
  • Targeting organelles allows for reduced drug dosage and minimized systemic toxicity.
  • This approach effectively overcomes multidrug resistance and prevents tumor recurrence.

Conclusions:

  • Organelle-targeted PDT represents a significant advancement in precision cancer therapy.
  • Future research should focus on overcoming challenges in clinical translation.
  • Optimizing photosensitizer design and understanding cell death pathways are crucial.